AU Patent

AU2007351866C1 — Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

Assigned to Siga Technologies Inc · Expires 2013-07-25 · 13y expired

What this patent protects

Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated …

USPTO Abstract

Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases cased by the orthopoxvirus.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007351866C1
Jurisdiction
AU
Classification
Expires
2013-07-25
Drug substance claim
No
Drug product claim
No
Assignee
Siga Technologies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.